,Title,SizeTEM (nm),Zeta potential,Incubation plasma concentration (v/v%),Incubation NP concentration (mg/L),Centrifugation speed (g),Centrifugation time （min）,Certrifugation temperature (℃),Dispersion medium pH,SizeDLS (nm),PDI,Incubation time (h),Incubation temperature (℃),Centrifugation repetitions,NP without modification_ADM105,NP without modification_ADM70,NP without modification_Ag,NP without modification_Au,NP without modification_Ca3(PO4)2,NP without modification_CaCO3,NP without modification_Chol-DC,NP without modification_Chol-PC,NP without modification_DC-Chol-DOPE,NP without modification_DOPC-DOPE-PEG-DSPC-DPPC,NP without modification_DOPG-DOPA,NP without modification_DOTAP,NP without modification_DOTAP-Chol,NP without modification_DOTAP-Chol-DPPC,NP without modification_DOTAP-Chol-DSPC,NP without modification_DOTAP-Chol-PC,NP without modification_DOTAP-DC-Chol,NP without modification_DOTAP-DOPC-DC-Chol-DOPE,NP without modification_DOTAP-DOPC-DC-Chol-DOPE/DOPE-PEG ,NP without modification_DOTAP-DOPE,NP without modification_DOTAP-DSPC-Chol,NP without modification_DOTAP/DNA,NP without modification_DOTAP/DOPC/DC-Chol/DOPE/DOPE-PEG2k,NP without modification_DOTAP:DOPC:DC-Chol:DOPE,NP without modification_DOTAP:DOPC:DC-Chol:DOPE-PEG,NP without modification_Fe3O4,NP without modification_HSPC-Chol,NP without modification_HSPC-Chol-DSPE,NP without modification_HSPC-Chol-DSPE-PEG20000,NP without modification_HSPC-DSPG-Chol,NP without modification_LPD,NP without modification_MWCNT,NP without modification_PS,NP without modification_PSOSO3,NP without modification_SWCNT,NP without modification_Shingosine-Chol-DSPC,NP without modification_Si,NP without modification_SiO2,NP without modification_TiO2,NP without modification_zeolite,Surface modification_AC,Surface modification_AHT,Surface modification_AUT,Surface modification_BCN,Surface modification_BPEI,Surface modification_CA,Surface modification_CALNN,Surface modification_CFGAILS,Surface modification_CIT,Surface modification_COOH,Surface modification_CTAB,Surface modification_CVVIT,Surface modification_DDT,Surface modification_DTNB,Surface modification_EMT,Surface modification_F127,Surface modification_FAU,Surface modification_HDA,Surface modification_LA,Surface modification_MAA,Surface modification_MBA,Surface modification_MES,Surface modification_MHA,Surface modification_MHDA,Surface modification_MPA,Surface modification_MSA,Surface modification_MUA,Surface modification_MUEG4,Surface modification_MUTA,Surface modification_NH2,Surface modification_NT,Surface modification_OAOA,Surface modification_ODA,Surface modification_OSO3,Surface modification_PAH-SH,Surface modification_PC,Surface modification_PEEP,Surface modification_PEG,Surface modification_PEI-SH,Surface modification_PVA,Surface modification_PVP,Surface modification_SA,Surface modification_SPP,Surface modification_SiO2,Surface modification_T20,Surface modification_TP,Surface modification_TiO2,Surface modification_amino acid,Surface modification_none,Surface modification_pDNA,Incubation protein source_FBS,Incubation protein source_HP,Incubation protein source_HS,Incubation protein source_RP,Incubation protein source_RS,NP type_carbon,NP type_liposome,NP type_metal,NP type_other,NP shape_powder,NP shape_rod,NP shape_sheet,NP shape_sphere,NP shape_star,NP shape_tube,Dispersion medium_PBS,Dispersion medium_buffer,Dispersion medium_cell culture,Dispersion medium_plasma,Dispersion medium_water,Incubation culture_DMEM,Incubation culture_buffer,Incubation culture_water,Modification type_Anionic,Modification type_Cationic,Modification type_Neutral,O95445
315,A proteomics-based methodology to investigate the protein corona effect for targeted drug delivery,60.0,58.4,50.0,500.0,84000,30,4,7.4,60.0,0.126944444,1.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,1,0.2
165,Phosphatidylcholine-Coated Iron Oxide Nanomicelles for in Vivo Prolonged Circulation Time with an Antibiofouling Protein Corona,7.0,-11.5,80.0,20.0,16000,120,10,7.4,74.9,0.14,1.5,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,1,0,0,0,0,0,1,0,1,0,0,0.166475309
441,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,31.6,-9.0,90.0,60.0,15300,20,4,7.4,75.0,0.051,120.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0.56
410,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,141.0,-6.0,90.0,60.0,15300,20,4,7.4,158.0,0.007,15.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0.09
414,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,144.8,-8.0,90.0,60.0,15300,20,4,7.4,172.0,0.009,0.5,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,1,0,1,0,0,0.21
49,Effect of DOPE and cholesterol on the protein adsorption onto lipid nanoparticles,90.8,51.2,50.0,500.0,15000,10,25,7.4,90.8,0.225,1.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,0.474614755
562,The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome,103.0,-38.7,50.0,500.0,15000,20,25,7.4,159.0,0.126944444,1.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,1,0,0,0,1,0.26
103,"Lipid composition: a ""key factor"" for the rational manipulation of the liposome-protein corona by liposome design",85.6,55.6,50.0,500.0,14000,15,25,7.4,85.6,0.126944444,1.0,37,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,0.076848298
396,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,129.0,-28.0,90.0,60.0,15300,20,4,7.4,133.0,0.006,15.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,1,0,1,0,0,0.17
567,The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome,103.0,-38.7,50.0,500.0,15000,20,25,7.4,159.0,0.126944444,168.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,1,0,0,0,0,0,1,0,0,0,1,0.37
42,Do plasma proteins distinguish between liposomes of varying charge density?,109.0,56.3,50.0,500.0,15000,10,25,7.0,109.0,0.212,1.0,37,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,0.143062699
35,"Differential analysis of ""protein corona"" profile adsorbed onto different nonviral gene delivery systems",200.0,50.0,50.0,500.0,15000,10,25,7.0,200.0,0.126944444,1.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,1,0.077224768
74,"In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles",121.82,-30.37,100.0,5.0,9000,20,25,7.4,100.98,0.15,0.166666667,37,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,1,0.82
327,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,30.2,-10.0,90.0,60.0,15300,20,4,7.4,31.0,0.104,30.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,1,0,1,0,0,0.44
109,"Lipid composition: a ""key factor"" for the rational manipulation of the liposome-protein corona by liposome design",210.0,-11.2,50.0,500.0,14000,15,25,7.4,210.0,0.126944444,1.0,37,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0.076848298
434,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,30.2,-9.0,90.0,60.0,15300,20,4,7.4,72.0,0.085,15.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,1,0,1,0,0,0.54
352,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,144.8,-18.0,90.0,60.0,15300,20,4,7.4,148.0,0.004,0.5,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,1,0,1,0,0,0.21
621,Zeolite Nanoparticles for Selective Sorption of Plasma Proteins,10.0,-44.0,10.0,40000.0,24000,30,25,7.0,10.0,0.126944444,1.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,0,1,0.73
50,Effect of DOPE and cholesterol on the protein adsorption onto lipid nanoparticles,78.8,55.7,50.0,500.0,15000,10,25,7.4,78.8,0.205,1.0,37,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,0.2429221
387,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,31.4,-25.0,90.0,60.0,15300,20,4,7.4,35.2,0.0001,2.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,0.35
123,Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: A comprehensive quantitative proteomic analysis,54.9,-32.0,50.0,1660.0,12000,10,4,7.4,71.3,0.126944444,1.0,4,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,0.090057357
366,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,27.2,-18.0,90.0,60.0,15300,20,4,7.4,28.0,0.063,60.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,1,0,1,0,0,0.34
524,Surface proteomics on nanoparticles: a step to simplify the rapid prototyping of nanoparticles,10.0,-9.62,10.0,100.0,2700,5,4,7.0,858.5,0.241,1.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0.08
488,Surface chemistry and serum type both determine the nanoparticle-protein corona,421.8,37.1,50.0,500.0,18000,15,25,7.4,421.8,0.126944444,1.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,0.32755996
413,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,141.0,-6.0,90.0,60.0,15300,20,4,7.4,158.0,0.007,120.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0.28
111,"Lipid composition: a ""key factor"" for the rational manipulation of the liposome-protein corona by liposome design",178.1,-2.1,50.0,500.0,14000,15,25,7.4,178.1,0.126944444,1.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0.474614755
360,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,27.2,-18.0,90.0,60.0,15300,20,4,7.4,28.0,0.063,15.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,1,0,1,0,0,0.4
193,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,59.3,-10.795,100.0,1888.699399,1500,45,4,7.4,94.45,0.106333333,1.0,37,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,1,0,0,0,0,0,1,0,0,1,0,1.6293
605,Visualization of the protein corona: Towards a biomolecular understanding of nanoparticle-cell-interactions,73.0,-13.5,77.0,10000.0,20000,60,4,7.0,73.0,0.126944444,1.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,0,1,0.05
531,Tailored Dual PEGylation of Inorganic Porous Nanocarriers for Extremely Long Blood Circulation in Vivo,82.0,-37.0,50.0,166.7,15000,20,25,7.0,165.0,0.126944444,1.5,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,0,1,1.3
477,The species origin of the serum in the culture medium influences the in vitro toxicity of silica nanoparticles to HepG2 cells,116.6,-19.9,10.0,1000.0,15000,20,25,7.4,220.8,0.288,24.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0.29
533,Time evolution of nanoparticle-protein corona in human plasma: Relevance for targeted drug delivery,130.0,55.0,50.0,500.0,14000,15,25,7.0,130.0,0.2,0.5,37,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,0,1,1.66
433,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,31.6,-9.0,90.0,60.0,15300,20,4,7.4,75.0,0.051,5.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0.49
548,The timeline of corona formation around silica nanocarriers highlights the role of the protein interactome,103.0,-15.1,50.0,500.0,15000,20,25,7.4,190.0,0.126944444,0.008333333,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0.25
52,Effect of polyethyleneglycol (PEG) chain length on the bio-nano- interactions between PEGylated lipid nanoparticles and biological fluids: From nanostructure to uptake in cancer cells,118.7,15.5,50.0,500.0,14000,15,25,7.0,118.7,0.126944444,1.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,0,1,0.607385811
438,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,30.2,-9.0,90.0,60.0,15300,20,4,7.4,72.0,0.085,60.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,1,0,1,0,0,0.47
386,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,31.4,-25.0,90.0,60.0,15300,20,4,7.4,35.2,0.0001,0.5,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,1,0.13
113,The liposome-protein corona in mice and humans and its implications for in vivo delivery,152.85,-13.74,50.0,500.0,14000,15,25,7.4,152.85,0.126944444,1.0,37,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0.327559962
606,Visualization of the protein corona: Towards a biomolecular understanding of nanoparticle-cell-interactions,73.0,-13.5,77.0,10000.0,20000,60,4,7.0,73.0,0.126944444,1.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,0,1,0.03
108,"Lipid composition: a ""key factor"" for the rational manipulation of the liposome-protein corona by liposome design",220.0,-10.6,50.0,500.0,14000,15,25,7.4,220.0,0.126944444,1.0,37,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0.118884316
114,The liposome-protein corona in mice and humans and its implications for in vivo delivery,208.0,-15.7,50.0,500.0,14000,15,25,7.4,208.0,0.126944444,1.0,37,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,1,0.057012617
